Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient treatment comparison for laryngopharyngeal reflux disease
ChiCTR2500103820Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esomeprazole in laryngopharyngeal reflux (LPR) (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Reflux Symptom Index (RSI) score. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
esomeprazole
03
Conditions
laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on ChiCTR2500103820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103820.